ArticleOncogene2016

HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.

P Peixoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.